Is Nomad Foods' Pricing Power Enough to Offset Protein Costs?

Nomad Foods (NOMD) faces rising protein input costs, particularly in chicken and red meat, due to increased demand and Asian flu-related disruptions, leading to a revised 2025 adjusted EBITDA growth guidance of 0-2%, down from 2-4%. While Q1 2025 gross margin rose to 27.8%, adjusted EBITDA declined 1.8% as pricing actions are expected to lag cost inflation, impacting profitability; shares have declined 5.5% in the past month. Peers like Conagra and Lamb Weston are also navigating inflationary pressures through portfolio restructuring and cost efficiencies, respectively.

Analysis

Nomad Foods (NOMD) is currently navigating significant headwinds from input cost inflation, particularly in key protein categories such as chicken and red meat, attributed to heightened demand and Asian flu-related disruptions in Europe. This pressure was evident in its first-quarter 2025 results, where despite a 90 basis point year-over-year increase in gross margin to 27.8%, adjusted EBITDA declined by 1.8%. Management has indicated that while pricing actions are being implemented, they are expected to lag behind the rising costs in the near term, leading to a downward revision of the 2025 adjusted EBITDA growth guidance to a 0% to 2% range, from a prior 2-4%. This situation poses a risk to consumer demand elasticity, especially in value-conscious markets like the United Kingdom. Reflecting these challenges, NOMD's shares have underperformed, declining approximately 5.5% in the past month, compared to a 1.7% decline for the industry. From a valuation perspective, NOMD trades at a forward price-to-earnings ratio of 7.89X, substantially lower than the industry average of 15.77X. Despite these operational pressures and recent stock performance, the Zacks Consensus Estimate projects year-over-year growth of 4.6% in sales and 7.3% in earnings per share for the current fiscal year, and the stock carries a Zacks Rank #1 (Strong Buy). Peers like Conagra Brands (CAG) are also experiencing significant margin compression from input costs, while Lamb Weston (LW) is focusing on cost efficiencies and volume growth amid strategic pricing adjustments.

Key Decisions for Investors

• Investors should closely monitor the pace and effectiveness of Nomad Foods' pricing strategies in mitigating protein cost inflation and assess the resultant impact on sales volumes and market share in upcoming quarters.
• The current valuation discount to peers, coupled with positive analyst consensus growth estimates and a 'Strong Buy' rating, warrants consideration, but this must be carefully weighed against the evident near-term margin pressures and the execution risk associated with cost recovery.
• Pay attention to evolving consumer behavior and demand elasticity in Nomad's key European markets, as sustained inflation could further challenge the company's ability to pass on costs without affecting volumes.
• Consider benchmarking Nomad Foods' performance against its peers, Conagra Brands and Lamb Weston, particularly regarding their differing strategies and success in navigating the inflationary environment and managing profitability.